Anti-Human FLT1 Recombinant Antibody
-
产品编号
YR1244
-
别名
科研级 Icrucumab ( 艾芦库单抗 ), Anti-FLT1 Recombinant Antibody, Research Grade Icrucumab
-
规格
- 1mg
- 5mg
Alias | 科研级 Icrucumab ( 艾芦库单抗 ), Anti-FLT1 Recombinant Antibody, Research Grade Icrucumab |
Catalog Number | YR1244 |
Molecular Name | Icrucumab |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG1 Kappa |
Formulation | PBS, pH7.5 |
Background | Icrucumab (IMC-18F1) is a human monoclonal antibody designed for the treatment of solid tumors. Icrucumab was developed by ImClone Systems Inc. It is undergoing Phase I trials. |
CAS Number | 1024603-92-6 |
Application | Neut, ELISA, IF, IP, FuncS, FCM, ICC |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Target | FLT1[Homo sapiens] |